8-K//Current report
Acrivon Therapeutics, Inc. 8-K
Accession 0001193125-25-280172
$ACRVCIK 0001781174operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:10 PM ET
Size
436.1 KB
Accession
0001193125-25-280172
Documents
- 8-Kacrv-20251113.htmPrimary
8-K
- EX-99.1acrv-ex99_1.htm
EX-99.1
- GRAPHICimg28311487_0.jpg
GRAPHIC
- EX-101.SCHacrv-20251113.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-280172-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLacrv-20251113_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeoperating
Related Parties
1- filerCIK 0001781174
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:10 PM ET
- Size
- 436.1 KB